These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 27272792

  • 21. Studies on two new mixed ligand platinum compounds with a trans-geometry.
    Al-Shuneigat J, Yu JQ, Beale P, Fisher K, Huq F.
    Med Chem; 2010 Sep; 6(5):321-8. PubMed ID: 20977416
    [Abstract] [Full Text] [Related]

  • 22. Combinations of resveratrol, cisplatin and oxaliplatin applied to human ovarian cancer cells.
    Nessa MU, Beale P, Chan C, Yu JQ, Huq F.
    Anticancer Res; 2012 Jan; 32(1):53-9. PubMed ID: 22213288
    [Abstract] [Full Text] [Related]

  • 23. Studies of interaction of trichloro{eta2-cis-N,N-dimethyl-1-[6-(N',N'-dimethyl-ammoniummethyl)-cyclohex-3-ene-1-yl]-methylammonium}platinum(II) chloride with DNA: Effects on secondary and tertiary structures of DNA. Cytotoxic assays on human ovarian cancer cell lines, resistant and non-resistant to cisplatin.
    Gay M, Montaña AM, Moreno V, Prieto MJ, Pérez JM, Alonso C.
    Bioorg Med Chem; 2006 Mar 01; 14(5):1565-72. PubMed ID: 16256352
    [Abstract] [Full Text] [Related]

  • 24. Synergism from combination of cisplatin and a trans-platinum compound in ovarian cancer cell lines.
    Alshehri A, Beale P, Yu JQ, Huq F.
    Anticancer Res; 2010 Nov 01; 30(11):4547-53. PubMed ID: 21115904
    [Abstract] [Full Text] [Related]

  • 25. Changes in the in vitro activity of platinum drugs when administered in two aliquots.
    Al-Eisawi Z, Beale P, Chan C, Yu JQ, Proschogo N, Molloy M, Huq F.
    BMC Cancer; 2016 Aug 26; 16(1):688. PubMed ID: 27566066
    [Abstract] [Full Text] [Related]

  • 26. Mechanisms of drug resistance to the platinum complex ZD0473 in ovarian cancer cell lines.
    Holford J, Beale PJ, Boxall FE, Sharp SY, Kelland LR.
    Eur J Cancer; 2000 Oct 26; 36(15):1984-90. PubMed ID: 11000581
    [Abstract] [Full Text] [Related]

  • 27. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
    Yang YI, Kim JH, Lee KT, Choi JH.
    Gynecol Oncol; 2011 Dec 26; 123(3):588-96. PubMed ID: 21945308
    [Abstract] [Full Text] [Related]

  • 28. Epigallocatechin gallate acts synergistically in combination with cisplatin and designed trans-palladiums in ovarian cancer cells.
    Mazumder ME, Beale P, Chan C, Yu JQ, Huq F.
    Anticancer Res; 2012 Nov 26; 32(11):4851-60. PubMed ID: 23155251
    [Abstract] [Full Text] [Related]

  • 29. Synthesis and activity of [{Cis-PtCl(NH3)2}2µ{trans-Pt(3-Hydroxypyridine)2(H2N(CH2)6NH2)2}]Cl4 in the human ovarian tumour models.
    Hamad SA, Beale P, Yu JQ, Fisher K, Huq F.
    Med Chem; 2012 May 26; 8(3):384-91. PubMed ID: 22530892
    [Abstract] [Full Text] [Related]

  • 30. Sequenced Combinations of Cisplatin and Selected Phytochemicals towards Overcoming Drug Resistance in Ovarian Tumour Models.
    Althurwi SI, Yu JQ, Beale P, Huq F.
    Int J Mol Sci; 2020 Oct 12; 21(20):. PubMed ID: 33053689
    [Abstract] [Full Text] [Related]

  • 31. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
    Horowitz NS, Hua J, Gibb RK, Mutch DG, Herzog TJ.
    Gynecol Oncol; 2004 Jul 12; 94(1):67-73. PubMed ID: 15262121
    [Abstract] [Full Text] [Related]

  • 32. Enhanced Accumulation of Cisplatin in Ovarian Cancer Cells from Combination with Wedelolactone and Resulting Inhibition of Multiple Epigenetic Drivers.
    Sarwar S, Alamro AA, Alghamdi AA, Naeem K, Ullah S, Arif M, Yu JQ, Huq F.
    Drug Des Devel Ther; 2021 Jul 12; 15():2211-2227. PubMed ID: 34079223
    [Abstract] [Full Text] [Related]

  • 33. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W, Chaney SG.
    Cancer Res; 1993 Feb 15; 53(4):799-805. PubMed ID: 8428361
    [Abstract] [Full Text] [Related]

  • 34. Synthesis, activity and binding with DNA of [{trans-PtCl(NH(3))(2)}(2)micro-{trans-Pd(4-hydroxypyridine) (2) (H(2)N(CH(2))(6)NH(2))(2)]Cl(4) (TH8).
    Huq F, Tayyem H, Yu JQ, Beale P, Fisher K.
    Med Chem; 2009 Jul 15; 5(4):372-81. PubMed ID: 19689395
    [Abstract] [Full Text] [Related]

  • 35. Mechanisms of acquired resistance to the orally active platinum-based anticancer drug bis-acetato-ammine-dichloro-cyclohexylamine platinum (i.v.) (JM216) in two human ovarian carcinoma cell lines.
    Mellish KJ, Kelland LR.
    Cancer Res; 1994 Dec 01; 54(23):6194-200. PubMed ID: 7954466
    [Abstract] [Full Text] [Related]

  • 36. Synthesis and activity of three new trinuclear platinums with cis-geometry for terminal metal centres.
    Hamad SA, Beale P, Yu JQ, Huq F.
    J Biomed Sci; 2014 May 12; 21(1):41. PubMed ID: 24884683
    [Abstract] [Full Text] [Related]

  • 37. In vitro studies on the mechanisms of oxaliplatin resistance.
    Hector S, Bolanowska-Higdon W, Zdanowicz J, Hitt S, Pendyala L.
    Cancer Chemother Pharmacol; 2001 Nov 12; 48(5):398-406. PubMed ID: 11761458
    [Abstract] [Full Text] [Related]

  • 38. High effectiveness of platinum(IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro.
    Kozubík A, Horváth V, Svihálková-Sindlerová L, Soucek K, Hofmanová J, Sova P, Kroutil A, Zák F, Mistr A, Turánek J.
    Biochem Pharmacol; 2005 Feb 01; 69(3):373-83. PubMed ID: 15652229
    [Abstract] [Full Text] [Related]

  • 39. Synergism from combinations of cisplatin and oxaliplatin with quercetin and thymoquinone in human ovarian tumour models.
    Nessa MU, Beale P, Chan C, Yu JQ, Huq F.
    Anticancer Res; 2011 Nov 01; 31(11):3789-97. PubMed ID: 22110201
    [Abstract] [Full Text] [Related]

  • 40. Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell lines.
    Coley HM, Sarju J, Wagner G.
    J Med Chem; 2008 Jan 10; 51(1):135-41. PubMed ID: 18072719
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.